Premium
Combining PUVA therapy with systemic immunosuppression to treat progressive diffuse morphoea
Author(s) -
Rose R. F.,
Goodfield M. J. D.
Publication year - 2005
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/j.1365-2230.2004.01693.x
Subject(s) - puva therapy , medicine , psoriasis , dermatology , immunosuppression , scleroderma (fungus) , tacrolimus , mycophenolate , organ transplantation , transplantation , surgery , immunology , inoculation
Summary Cyclosporin and mycophenolate mofetil (MMF) are immunosuppressant agents now used frequently in the field of organ transplantation. More recently cyclosporin has been used for the treatment of a number of dermatological conditions, including severe psoriasis and eczema. Extensive diffuse morphoea is very difficult to treat. PUVA, UVA and a number of immunomodulating drugs have been used to attempt improvement but are most beneficial only in early disease. Combination treatments are often used in psoriasis, for example, but are not reported in morphoea. We present the case of a patient treated initially with cyclosporin and PUVA and subsequently with MMF and PUVA, with considerable improvement in his condition.